For over 35 years, SeerPharma has served as a trusted partner to life science organisations across the Asia-Pacific (APAC) region, supporting them in navigating complex challenges related to Quality Assurance and GxP compliance.
There is a growing and sustained interest from US and EU biotechnology companies in partnering with APAC-based organisations for clinical trial support and commercial manufacturing as part of their global product development strategies.
In response to this trend, SeerPharma is routinely engaged by US and EU companies to perform:
These assessments are conducted in alignment with FDA and/or EU (PIC/S) regulatory standards, delivering essential assurance to biotech firms seeking to partner with manufacturers in the region.
To support the increasing demand for these services, SeerPharma Director Andrew Giles will join the official Australian trade delegation at the BIO International Convention 2025, taking place in Boston from 16–19 June.
Andrew leads SeerPharma’s GMP inspection programs and brings extensive experience, having conducted inspections at more than 400 facilities across China, India, Japan, Korea, Singapore, and Australia. At BIO 2025, Andrew will be available to engage with US and EU biotech stakeholders, addressing regulatory queries and sharing insights based on his comprehensive industry knowledge.
In addition, Andrew will work alongside other Australian delegates to support domestic clinical trial and CDMO operations in their engagements with current and prospective international clients, offering regulatory insights into the GMP landscape across the APAC region.
Recognised as the largest and most influential global event in biotechnology, the BIO International Convention attracts more than 20,000 leaders from across the life sciences ecosystem.
For more information about BIO 2025, visit: https://convention.bio.org/bio-2025
If you’re attending and would like to connect, we invite you to reach out to SeerPharma via our contact page.
If you would like to learn more about our ability to support you with GxP inspections across the APAC region, visit our GxP auditing page.
SeerPharma’s participation in events like BIO 2025 is part of our enduring commitment to our mission: Advancing Quality and GMP Best Practices in the APAC Region.